AU2013344654A1 - Oral transmucosal drug delivery system - Google Patents

Oral transmucosal drug delivery system

Info

Publication number
AU2013344654A1
AU2013344654A1 AU2013344654A AU2013344654A AU2013344654A1 AU 2013344654 A1 AU2013344654 A1 AU 2013344654A1 AU 2013344654 A AU2013344654 A AU 2013344654A AU 2013344654 A AU2013344654 A AU 2013344654A AU 2013344654 A1 AU2013344654 A1 AU 2013344654A1
Authority
AU
Australia
Prior art keywords
delivery system
drug delivery
oral transmucosal
transmucosal drug
oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2013344654A
Other versions
AU2013344654B2 (en
Inventor
Salah U. Ahmed
Tahseen A. Chowdhury
Saad MUNTAZIM
Karunakar Neelam
Shiying TIAN
Yanming Zu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abon Pharmaceuticals LLC
Original Assignee
Abon Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abon Pharmaceuticals LLC filed Critical Abon Pharmaceuticals LLC
Priority claimed from PCT/US2013/070162 external-priority patent/WO2014078576A2/en
Publication of AU2013344654A1 publication Critical patent/AU2013344654A1/en
Assigned to ABON PHARMACEUTICALS, LLC reassignment ABON PHARMACEUTICALS, LLC Request for Assignment Assignors: ABON PHARMACEUTICALS, LLC, AHMED, SALAH, CHOWDHURY, TAHSEEN, MUNTAZIM, Saad, NEELAM, KARUNAKAR, TIAN, Shiying, ZU, YANMING
Priority to AU2017203861A priority Critical patent/AU2017203861B2/en
Application granted granted Critical
Publication of AU2013344654B2 publication Critical patent/AU2013344654B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

AU2013344654A 2012-11-14 2013-11-14 Oral transmucosal drug delivery system Active AU2013344654B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2017203861A AU2017203861B2 (en) 2012-11-14 2017-06-07 Oral Transmucosal Drug Delivery System

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261726475P 2012-11-14 2012-11-14
US61/726,475 2012-11-14
PCT/US2013/070162 WO2014078576A2 (en) 2012-11-14 2013-11-14 Oral transmucosal drug delivery system

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2017203861A Division AU2017203861B2 (en) 2012-11-14 2017-06-07 Oral Transmucosal Drug Delivery System

Publications (2)

Publication Number Publication Date
AU2013344654A1 true AU2013344654A1 (en) 2015-05-28
AU2013344654B2 AU2013344654B2 (en) 2017-06-22

Family

ID=50728504

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2013344654A Active AU2013344654B2 (en) 2012-11-14 2013-11-14 Oral transmucosal drug delivery system
AU2017203861A Active AU2017203861B2 (en) 2012-11-14 2017-06-07 Oral Transmucosal Drug Delivery System

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2017203861A Active AU2017203861B2 (en) 2012-11-14 2017-06-07 Oral Transmucosal Drug Delivery System

Country Status (7)

Country Link
US (3) US9352047B2 (en)
EP (1) EP2919767B1 (en)
AU (2) AU2013344654B2 (en)
CA (1) CA2898729C (en)
ES (1) ES2802050T3 (en)
HK (1) HK1215529A1 (en)
WO (1) WO2014078576A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2802050T3 (en) * 2012-11-14 2021-01-15 Abon Pharmaceuticals Llc Oral transmucosal drug delivery system
AR102214A1 (en) * 2015-10-08 2017-02-15 Amarin Tech S A A DEVICE FOR THE TRANSDERMAL ADMINISTRATION OF BUPRENORFINA
WO2018090096A1 (en) * 2016-11-18 2018-05-24 The University Of Western Australia Taste masking product
DE102017104277A1 (en) * 2017-03-01 2018-09-06 Lts Lohmann Therapie-Systeme Ag Transmucosal administration system for idebenone
US11413271B2 (en) * 2018-06-11 2022-08-16 Abon Pharmaceuticals Llc Oral eliglustat transmucosal delivery system
US11813354B1 (en) * 2019-01-11 2023-11-14 Shear Kershman Laboratories, Inc Trans-mucosal delivery system for testosterone
US11485554B2 (en) 2019-02-22 2022-11-01 Board Of Trustees Of Michigan State University Methods for extracting and encapsulating phenolics from food waste, related compositions, and related articles
WO2020243538A1 (en) * 2019-05-31 2020-12-03 Primo Pharmatech Llc Unit dosage form for transmucosal drug delivery of an active pharmaceutical ingredient
CN113952312A (en) * 2021-10-24 2022-01-21 重庆市力扬医药开发有限公司 Silodosin medicine absorbed through oral mucosa

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050180923A1 (en) * 1997-10-01 2005-08-18 Dugger Harry A.Iii Buccal, polar and non-polar spray containing testosterone
IT1298575B1 (en) * 1998-02-06 2000-01-12 Vectorpharma Int PHARMACEUTICAL COMPOSITIONS IN THE FORM OF NANOPARTICLES INCLUDING LIPID SUBSTANCES AND ANTIPHILIC SUBSTANCES AND RELATED PROCESS OF
US6284262B1 (en) * 1999-01-26 2001-09-04 Virgil A. Place Compact dosage unit for buccal administration of a pharmacologically active agent
US6465004B1 (en) * 1999-06-05 2002-10-15 Noven Pharmaceuticals, Inc. Solubility enhancement of drugs in transdermal drug delivery systems and methods of use
ES2299441T3 (en) * 1999-12-08 2008-06-01 Pharmacia Corporation SOLID STATE FORM OF CELECOXIB WITH POWERFUL BIODISPONIBILITY.
US20030091630A1 (en) 2001-10-25 2003-05-15 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
FR2834897B1 (en) * 2002-01-23 2004-02-27 Servier Lab ORODISPERSIBLE PHARMACEUTICAL COMPOSITION OF TESTOSTERONE
ATE452641T1 (en) * 2002-09-05 2010-01-15 Pantarhei Bioscience Bv ORAL PHARMACEUTICAL COMPOSITION CONTAINING 15-HYDROXYTESTOSTERONE AND ITS DERIVATIVES
CA2516816C (en) * 2003-02-24 2012-02-07 Pharmaceutical Productions, Inc. Transmucosal drug delivery system
CA2603649C (en) * 2005-04-08 2014-10-14 Ozpharma Pty Ltd Buccal delivery system
WO2006125642A1 (en) * 2005-05-27 2006-11-30 Antares Pharma Ipl Ag Methods and apparatus for transdermal or transmucosal application of testosterone
MX2007014986A (en) 2005-06-03 2008-02-15 Duramed Pharmaceuticals Inc Attachment of a handle to a solid oral dosage form.
US7908729B2 (en) 2005-06-03 2011-03-22 Teva Women's Health, Inc. Method for making a lollipop
DE102006003512A1 (en) * 2006-01-24 2007-08-02 Bayer Schering Pharma Ag Film-forming transmucosal medicament, useful for administering active agents such as androgens, gestagens and estrogens, comprises a film former, which disintegrates in an aqueous medium, and cyclodextrin or its derivatives
EP1867321A3 (en) * 2006-06-07 2008-11-19 Familplan Consulting Ltd. A pharmaceutical product adapted for oral transmucosal administration comprising a pharmaceutical agent
CN1903056B (en) * 2006-08-01 2010-12-08 北京健健康康生物技术有限公司 Xylitox coffee products for chewing or instant dissolving, and its prepn. method
US20080131504A1 (en) 2006-12-01 2008-06-05 Mission Pharmacal Co. Short Term Slow Release Drug Delivery System
US20080286340A1 (en) * 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered nicotine containing products
WO2009027644A2 (en) 2007-08-24 2009-03-05 Stichting Het Nederlands Kanker Instituut Composition
ES2802050T3 (en) * 2012-11-14 2021-01-15 Abon Pharmaceuticals Llc Oral transmucosal drug delivery system

Similar Documents

Publication Publication Date Title
ZA201502352B (en) Liposomal drug delivery system
EP2906202A4 (en) Oral drug delivery formulations
PL2654864T3 (en) System for drug delivery
GB2491327B (en) Delayed prolonged drug delivery
EP2665503A4 (en) Medicament delivery device
HK1215529A1 (en) Oral transmucosal drug delivery system
AU2013344654A1 (en) Oral transmucosal drug delivery system
EP2804596B8 (en) Transmucosal administration system for a pharmaceutical drug
HUE062316T2 (en) Drug delivery technology
ZA201309156B (en) Drug delivery system
IL227352A0 (en) Ocular drug delivery system
IL236757A0 (en) Gastro-retentive drug delivery system
HK1203802A1 (en) A drug delivery system
HRP20181316T1 (en) Drug delivery technology
GB201210628D0 (en) Oral medicine dispensing system
HK1214522A1 (en) Oral transmucosal delivery of glatiramer acetate
EP2632902A4 (en) Improved oral targetted drug delivery system
GB201110632D0 (en) Drug delivery formulations
GB201018750D0 (en) Drug delivery system
AU2010902059A0 (en) Novel drug delivery system
AU2010904901A0 (en) Drug delivery device
AU2012901190A0 (en) Liposome Compositions and Systems for Drug Delivery
GB201005639D0 (en) Drug delivery formulations